Bronchial asthma is the syndrome, characterized with chronic inflammation, hyperreactivity and obstruction of the respiratory pathways, accompanied with consequential symptoms and remodeling of the respiratory pathways. Application of inhaled corticosteroids accompanied with appropriate education of patients, significantly improve therapeutic treatment and outcome of the asthma. But, improvement of the lung function and patients subjective state is remarkable better yif inhaled corticosteroids are combined with adrenergic â2 agonists, than if the dose of inhaled corticosteroids is increased. So, according to Global initiative for asthma and clinical results long acting adrenergic â2 agonists in combination with inhaled corticosteroids are most efficient in asthma treatment and establishment and conservation of bronchial asthma control.